Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.02
09.01.22
-
09.01.23
-18.54%
23.01.22

Could be very worthwhile Investment >20% year
blaugold 
09.01.22 50%
sell
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.66
09.01.22
€0.20
09.01.23
-1.09%
21.07.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
09.01.22 50%
sell
Novocure Ltd

Start price
Target price
Perf. (%)
€59.26
09.01.22
€51.00
09.01.23
8.34%
16.03.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
geldnutzer 
09.01.22 70%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€3.71
09.01.22
-
09.01.23
-11.02%
22.01.22

Could be worthwhile Investment >10% per year
bundfuture 
09.01.22 50%
sell
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€13.26
09.01.22
-
09.01.23
7.05%
10.01.23

Risky Investment
Lokrim 
09.01.22 20%
sell
Precision BioSciences Inc

Start price
Target price
Perf. (%)
€5.87
09.01.22
-
09.01.23
-79.37%
10.01.23

Probably not worthwhile Investment
Lokrim 
09.01.22 20%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€30.80
08.01.22
-
08.01.26
-46.20%
05.09.22

Probably not worthwhile Investment
Lutz69 
08.01.22 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€196.52
08.01.22
€915.00
14.01.27
132.19%
26.07.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
Karakorum 
08.01.22 80%
buy
Magenta Therapeutics

Start price
Target price
Perf. (%)
€4.08
08.01.22
€6.00
08.01.23
-26.40%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
nvestor 
08.01.22 50%
buy
Immuron

Start price
Target price
Perf. (%)
€2.10
08.01.22
€4.00
08.01.23
39.05%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
nvestor 
08.01.22 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€114.10
07.01.22
€130.00
07.01.23
-63.63%
05.06.22

Could be worthwhile Investment >10% per year
melinda 
07.01.22 50%
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€19.50
06.01.22
-
06.01.23
-45.13%
13.03.22

Kilianhammernick 
06.01.22 50%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€18.94
05.01.22
-
05.01.23
-7.08%
09.01.22

Risky Investment
Global_Player 
05.01.22 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€19.03
04.01.22
-
04.01.23
-7.46%
07.01.22

Risky Investment
thomasw 
04.01.22 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€50.01
03.01.22
€78.00
03.01.23
-2.98%
04.01.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
Konrad 
03.01.22 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.54
03.01.22
-
03.01.23
-14.69%
09.01.22

Risky Investment
Wolf_of_WS 
03.01.22 50%
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€33.72
03.01.22
-
03.01.23
-14.00%
09.01.22

Risky Investment
Vassago1 
03.01.22 50%
buy
Quantum Genomics S.A.

Start price
Target price
Perf. (%)
€4.32
31.12.21
€5.00
31.12.22
-97.78%
01.01.23

Could be worthwhile Investment >10% per year
melinda 
31.12.21 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€134.44
30.12.21
-
30.12.22
-13.81%
09.01.22

Risky Investment
Vassago1 
30.12.21 50%
buy
Oramed Pharmaceuticals

Start price
Target price
Perf. (%)
€11.38
29.12.21
€15.00
29.12.22
-0.92%
30.12.22

Could be worthwhile Investment >10% per year
melinda 
29.12.21 50%
sell
Oramed Pharmaceuticals

Start price
Target price
Perf. (%)
€10.70
29.12.21
-
29.12.22
5.37%
30.12.22

Risky Investment
Mainly gamblers invest here
Sustainability is not important
High valuation
Amped 
29.12.21 0%
buy
GSK plc

Start price
Target price
Perf. (%)
€19.38
29.12.21
-
29.12.22
-15.38%
30.12.22

Maxi_Scalibusa 
29.12.21 50%
sell
BiondVax Pharmaceuticals Ltd ADR

Start price
Target price
Perf. (%)
€22.60
28.12.21
-
28.12.22
-32.74%
07.01.22

Probably not worthwhile Investment
tinelchen 
28.12.21 0%
buy
Opko Health Inc.

Start price
Target price
Perf. (%)
€4.65
28.12.21
-
28.12.22
-75.54%
29.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Maxi_Scalibusa 
28.12.21 0%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€149.96
28.12.21
-
28.12.22
10.44%
29.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good culture
Top 10 in its market
Maxi_Scalibusa 
28.12.21 50%